Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
North Sound Capital LLC, et al v. Merck & Co Inc, et al
Case Number:
16-1367
Court:
Nature of Suit:
3850 Securities, Commodities, Exchange
Companies
- Illinois Municipal Retirement Fund
- Orange County Employees Retirement System
- PGGM Investments
- Professional Footballers Association Enterprises Ltd.
- Public Citizen Inc.
- SIFMA
- Southeastern Pennsylvania Transportation Authority
- Universities Superannuation Scheme Ltd.
- Virginia Retirement System
Government Agencies
- California Public Employees' Retirement System
- New York State Comptroller
- Wisconsin Investment Board
Sectors & Industries:
-
August 02, 2017
Merck Investors' Claims Time-Barred, 3rd Circ. Finds
The Third Circuit Wednesday found a June U.S. Supreme Court ruling established investors' claims that Merck & Co. Inc. misrepresented results of a clinical trial of its anti-cholesterol drug Vytorin were filed too late to bring a Securities and Exchange Act case.
-
August 17, 2016
Dusek Doesn't Bar Merck Investors' Claims, 3rd Circ. Hears
Institutional funds claiming Merck & Co Inc. misrepresented clinical trial results for its anti-cholesterol drug Vytorin told the Third Circuit on Tuesday that a recent Eleventh Circuit decision concerning the so-called American Pipe tolling standard does not apply to Merck's timeliness challenge to the funds' claims.
-
July 12, 2016
Securities Cases To Watch In The 2nd Half Of 2016
The back half of 2016 promises to be exciting for securities lawyers, as the U.S. Supreme Court considers its first insider trading case in nearly 20 years, the D.C. Circuit prepares to rule on the U.S. Securities and Exchange Commission's administrative tribunal, and the U.S. Department of Labor defends challenges to its fiduciary rule.
-
June 01, 2016
CalPERS Backs Merck Investors In 3rd Circ. Tolling Fight
The California Public Employees' Retirement System on Tuesday threw its support behind a group of institutional funds fighting Merck's challenge of the timeliness of their misrepresentation claims over the drugmaker's anti-cholesterol drug Vytorin, telling the Third Circuit that the claims were timely and otherwise preserved by the so-called American Pipe tolling standard.